99 related articles for article (PubMed ID: 19423181)
1. Denial and physical outcomes in lung cancer patients, a longitudinal study.
Vos MS; Putter H; van Houwelingen HC; de Haes HC
Lung Cancer; 2010 Feb; 67(2):237-43. PubMed ID: 19423181
[TBL] [Abstract][Full Text] [Related]
2. Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial.
Vos MS; Putter H; van Houwelingen HC; de Haes HC
Lung Cancer; 2011 Apr; 72(1):119-24. PubMed ID: 20705356
[TBL] [Abstract][Full Text] [Related]
3. Denial in lung cancer patients: a longitudinal study.
Vos MS; Putter H; van Houwelingen HC; de Haes HC
Psychooncology; 2008 Dec; 17(12):1163-71. PubMed ID: 18823062
[TBL] [Abstract][Full Text] [Related]
4. The denial of cancer interview: development and first assessment of psychometric properties in lung cancer patients.
Vos MS; Putter H; Leurs A; Rooijmans HG; de Haes HC; van Houwelingen HC
Patient Educ Couns; 2007 Jul; 67(1-2):224-34. PubMed ID: 17498908
[TBL] [Abstract][Full Text] [Related]
5. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients.
Wang XS; Cleeland CS; Mendoza TR; Engstrom MC; Liu S; Xu G; Hao X; Wang Y; Ren XS
Cancer; 1999 Nov; 86(9):1848-55. PubMed ID: 10547560
[TBL] [Abstract][Full Text] [Related]
6. ['Doctor, I don't want to know that'--exploring denial in patients with lung cancer].
Vos MS; Berendsen HH
Ned Tijdschr Geneeskd; 2001 Dec; 145(50):2409-12. PubMed ID: 11776664
[TBL] [Abstract][Full Text] [Related]
7. Joint analysis of multiple longitudinal outcomes: application of a latent class model.
Putter H; Vos T; de Haes H; van Houwelingen H
Stat Med; 2008 Dec; 27(29):6228-49. PubMed ID: 18816496
[TBL] [Abstract][Full Text] [Related]
8. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
9. Denial in cancer patients, an explorative review.
Vos MS; de Haes JC
Psychooncology; 2007 Jan; 16(1):12-25. PubMed ID: 16868929
[TBL] [Abstract][Full Text] [Related]
10. Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.
Tishelman C; Petersson LM; Degner LF; Sprangers MA
J Clin Oncol; 2007 Dec; 25(34):5381-9. PubMed ID: 18048819
[TBL] [Abstract][Full Text] [Related]
11. Framing the onset of lung cancer biographically: narratives of continuity and disruption.
Leveälahti H; Tishelman C; Ohlén J
Psychooncology; 2007 May; 16(5):466-73. PubMed ID: 16915570
[TBL] [Abstract][Full Text] [Related]
12. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis.
Corner J; Hopkinson J; Fitzsimmons D; Barclay S; Muers M
Thorax; 2005 Apr; 60(4):314-9. PubMed ID: 15790987
[TBL] [Abstract][Full Text] [Related]
13. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
[TBL] [Abstract][Full Text] [Related]
14. Intervention to improve psychological functioning for newly diagnosed patients with cancer.
Rawl SM; Given BA; Given CW; Champion VL; Kozachik SL; Kozachik SL; Barton D; Emsley CL; Williams SD
Oncol Nurs Forum; 2002 Jul; 29(6):967-75. PubMed ID: 12096294
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer.
Lo C; Zimmermann C; Rydall A; Walsh A; Jones JM; Moore MJ; Shepherd FA; Gagliese L; Rodin G
J Clin Oncol; 2010 Jun; 28(18):3084-9. PubMed ID: 20479397
[TBL] [Abstract][Full Text] [Related]
16. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.
Newell S; Sanson-Fisher RW; Girgis A; Bonaventura A
Cancer; 1998 Oct; 83(8):1640-51. PubMed ID: 9781960
[TBL] [Abstract][Full Text] [Related]
17. HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer.
Rolke HB; Bakke PS; Gallefoss F
Clin Respir J; 2010 Jul; 4(3):168-75. PubMed ID: 20565496
[TBL] [Abstract][Full Text] [Related]
18. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Sarna L; Swann S; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Byhardt R; Wasserman T; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1378-84. PubMed ID: 18501528
[TBL] [Abstract][Full Text] [Related]
19. 'A little bitty spot and I'm a big man': patients' perspectives on refusing diagnosis or treatment for lung cancer.
Sharf BF; Stelljes LA; Gordon HS
Psychooncology; 2005 Aug; 14(8):636-46. PubMed ID: 15744761
[TBL] [Abstract][Full Text] [Related]
20. Loss of physical functioning among patients with cancer: a longitudinal view.
Kurtz ME; Kurtz JC; Given CW; Given B
Cancer Pract; 1993; 1(4):275-81. PubMed ID: 8111437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]